BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 6278769)

  • 1. [Role of immunotherapy in the combined treatment of lung cancer].
    Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
    Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-specific immunostimulation in bronchogenic cancer.
    Israel L
    Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].
    Fujisawa T
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):13-20. PubMed ID: 2981513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
    Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
    Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy of lung cancer].
    Jassem J; Jassem E
    Pol Tyg Lek; 1982 Jun; 37(17):497-9. PubMed ID: 6292882
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
    Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
    Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
    Warren SE; Crispen RG; Nika B
    Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy of carcinoma of the lung].
    Sega E; Mineo TC; Rea SR; Sega FM; Ricci C
    Recenti Prog Med; 1978 Mar; 64(3):293-309. PubMed ID: 351751
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of lung cancer.
    Zubrod CG; Selawry O
    Adv Intern Med; 1978; 23():451-67. PubMed ID: 204171
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
    Azuma I; Yamamura Y
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
    Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
    Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin.
    Grant SC; Kris MG; Houghton AN; Chapman PB
    Clin Cancer Res; 1999 Jun; 5(6):1319-23. PubMed ID: 10389914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibodies to lung cancer antigens (a review of the literature)].
    Tkacheva GA
    Med Radiol (Mosk); 1989 May; 34(5):62-75. PubMed ID: 2542715
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune status in lung cancer: effects of BCG immunotherapy.
    Gross NJ; Eddie-Quartey AC
    Am Rev Respir Dis; 1976 Apr; 113(4):457-64. PubMed ID: 178255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the immunologic system in patients with small cell and squamous cell lung cancer during the early stage of treatment].
    Janicka G; Chyczewska E; Przylipiak M; Kowal E
    Pol Tyg Lek; 1985 Aug; 40(34):963-6. PubMed ID: 2999734
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
    Takano T; Morishita M; Yamamoto M; Yamagata K; Takada K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant systemic therapy of lung cancer.
    Muggia FM; McGuire WP
    Cancer Clin Trials; 1978; 1(3):235-41. PubMed ID: 229981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reevaluation of immunopotentiation therapy for cancer].
    Toyoshima K
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):817-23. PubMed ID: 10897207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung.
    Lachmann PJ; Grant RM; Freedman LS; Sikora K; Bleehen NM
    Br J Cancer; 1985 Mar; 51(3):415-7. PubMed ID: 3882114
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunotherapy in bronchial carcinoma].
    Havemann K
    Onkologie; 1980 Jun; 3(3):120-6. PubMed ID: 6258119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.